Latest Breaking News On - Karl ziegelbauer - Page 1 : comparemela.com

Almirall, S.A.: Almirall and Eloxx Pharmaceuticals Enter into Exclusive Agreement to License ZKN-013 for Rare Dermatological Diseases

Almirall, S.A.: Almirall and Eloxx Pharmaceuticals Enter into Exclusive Agreement to License ZKN-013 for Rare Dermatological Diseases
finanznachrichten.de - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from finanznachrichten.de Daily Mail and Mail on Sunday newspapers.

Barcelona
Comunidad-autonoma-de-cataluna
Spain
Spanish
John-woolford
Stefan-klotter
Sumit-aggarwal
Karl-ziegelbauer
Laureen-cassidy
Eloxx-pharmaceuticals-inc
Eloxx-pharmaceuticals
Corporate-communications

Almirall and Eloxx Pharmaceuticals Enter into Exclusive Agreement to License ZKN-013 for Rare Dermatological Diseases

Almirall obtains exclusive global rights to develop and commercialize ZKN-013 for the treatment of rare dermatological and other diseases associated with nonsense mutations ZKN-013 is a phase I.

Barcelona
Comunidad-autonoma-de-cataluna
Spain
Spanish
Sumit-aggarwal
Karl-ziegelbauer
Spanish-stock-exchange
Eloxx-pharmaceuticals-inc
Eloxx-pharmaceuticals
Chief-executive-officer
Chief-scientific-officer
Ribosome-modulating-agents

Almirall gains rights to Eloxx's rare dermatological disease asset in deal worth over $470m

Almirall gains rights to Eloxx's rare dermatological disease asset in deal worth over $470m
pmlive.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from pmlive.com Daily Mail and Mail on Sunday newspapers.

Sumit-aggarwal
Karl-ziegelbauer
Eloxx-pharmaceuticals
Novo-nordisk

Almirall and Eloxx Pharmaceuticals Enter into Exclusive

Almirall obtains exclusive global rights to develop and commercialize ZKN-013 for the treatment of rare dermatological and other diseases associated with.

Barcelona
Comunidad-autonoma-de-cataluna
Spain
Spanish
Sumit-aggarwal
Karl-ziegelbauer
Spanish-stock-exchange
Eloxx-pharmaceuticals-inc
Eloxx-pharmaceuticals
Dystrophic-epidermolysis-bullosa
Junctional-epidermolysis-bullosa
Chief-executive-officer

Almirall gains rights to Novo Nordisk's IL-21 blocker for dermatological diseases

Almirall gains rights to Novo Nordisk's IL-21 blocker for dermatological diseases
pmlive.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from pmlive.com Daily Mail and Mail on Sunday newspapers.

Karl-ziegelbauer
Novo-nordisk
Nostrum-biodiscovery